nodes	percent_of_prediction	percent_of_DWPC	metapath
Nevirapine—CYP2A6—Methoxsalen—hematologic cancer	0.0344	0.0476	CbGbCtD
Nevirapine—CYP1A2—Anagrelide—hematologic cancer	0.0294	0.0407	CbGbCtD
Nevirapine—CYP2B6—Thiotepa—hematologic cancer	0.0288	0.0398	CbGbCtD
Nevirapine—CYP2A6—Ifosfamide—hematologic cancer	0.0251	0.0347	CbGbCtD
Nevirapine—CYP2C9—Bexarotene—hematologic cancer	0.0184	0.0254	CbGbCtD
Nevirapine—CYP2A6—Prednisolone—hematologic cancer	0.0167	0.0231	CbGbCtD
Nevirapine—CYP2B6—Ifosfamide—hematologic cancer	0.0163	0.0226	CbGbCtD
Nevirapine—CYP3A5—Daunorubicin—hematologic cancer	0.0161	0.0222	CbGbCtD
Nevirapine—CYP2D6—Lomustine—hematologic cancer	0.0156	0.0216	CbGbCtD
Nevirapine—CYP1A2—Carmustine—hematologic cancer	0.0155	0.0214	CbGbCtD
Nevirapine—CYP2C9—Idarubicin—hematologic cancer	0.0152	0.021	CbGbCtD
Nevirapine—CYP3A5—Thalidomide—hematologic cancer	0.0146	0.0202	CbGbCtD
Nevirapine—CYP2B6—Nilotinib—hematologic cancer	0.0142	0.0196	CbGbCtD
Nevirapine—CYP3A5—Teniposide—hematologic cancer	0.014	0.0193	CbGbCtD
Nevirapine—CYP2D6—Idarubicin—hematologic cancer	0.0139	0.0192	CbGbCtD
Nevirapine—CYP1A2—Methoxsalen—hematologic cancer	0.0131	0.0182	CbGbCtD
Nevirapine—CYP3A5—Ifosfamide—hematologic cancer	0.0129	0.0178	CbGbCtD
Nevirapine—CYP1A2—Bortezomib—hematologic cancer	0.0125	0.0173	CbGbCtD
Nevirapine—CYP3A5—Imatinib—hematologic cancer	0.0123	0.017	CbGbCtD
Nevirapine—CYP1A2—Daunorubicin—hematologic cancer	0.012	0.0165	CbGbCtD
Nevirapine—CYP2D6—Hydroxyurea—hematologic cancer	0.0118	0.0164	CbGbCtD
Nevirapine—CYP1A2—Alitretinoin—hematologic cancer	0.0117	0.0162	CbGbCtD
Nevirapine—CYP2C9—Bortezomib—hematologic cancer	0.0113	0.0156	CbGbCtD
Nevirapine—CYP1A2—Thalidomide—hematologic cancer	0.0109	0.015	CbGbCtD
Nevirapine—CYP3A4—Bexarotene—hematologic cancer	0.0107	0.0148	CbGbCtD
Nevirapine—CYP2D6—Bortezomib—hematologic cancer	0.0103	0.0142	CbGbCtD
Nevirapine—CYP3A4—Lomustine—hematologic cancer	0.00993	0.0137	CbGbCtD
Nevirapine—CYP3A4—Busulfan—hematologic cancer	0.00993	0.0137	CbGbCtD
Nevirapine—CYP3A5—Dasatinib—hematologic cancer	0.00988	0.0137	CbGbCtD
Nevirapine—CYP2A6—Dexamethasone—hematologic cancer	0.00987	0.0136	CbGbCtD
Nevirapine—CYP2C9—Thalidomide—hematologic cancer	0.00981	0.0136	CbGbCtD
Nevirapine—CYP2B6—Irinotecan—hematologic cancer	0.00975	0.0135	CbGbCtD
Nevirapine—CYP1A2—Dacarbazine—hematologic cancer	0.00936	0.0129	CbGbCtD
Nevirapine—CYP2C9—Teniposide—hematologic cancer	0.00936	0.0129	CbGbCtD
Nevirapine—CYP1A2—Imatinib—hematologic cancer	0.00915	0.0127	CbGbCtD
Nevirapine—CYP3A4—Thiotepa—hematologic cancer	0.00885	0.0122	CbGbCtD
Nevirapine—CYP2C9—Ifosfamide—hematologic cancer	0.00864	0.0119	CbGbCtD
Nevirapine—CYP2C9—Imatinib—hematologic cancer	0.00825	0.0114	CbGbCtD
Nevirapine—CYP2B6—Cisplatin—hematologic cancer	0.00795	0.011	CbGbCtD
Nevirapine—CYP3A5—Irinotecan—hematologic cancer	0.00768	0.0106	CbGbCtD
Nevirapine—CYP2D6—Imatinib—hematologic cancer	0.00754	0.0104	CbGbCtD
Nevirapine—CYP2C9—Nilotinib—hematologic cancer	0.0075	0.0104	CbGbCtD
Nevirapine—CYP1A2—Dasatinib—hematologic cancer	0.00735	0.0102	CbGbCtD
Nevirapine—CYP3A4—Methoxsalen—hematologic cancer	0.00688	0.00951	CbGbCtD
Nevirapine—CYP2D6—Nilotinib—hematologic cancer	0.00685	0.00947	CbGbCtD
Nevirapine—CYP2D6—Vinorelbine—hematologic cancer	0.0068	0.0094	CbGbCtD
Nevirapine—CYP3A5—Vincristine—hematologic cancer	0.00672	0.00928	CbGbCtD
Nevirapine—CYP3A4—Bortezomib—hematologic cancer	0.00655	0.00905	CbGbCtD
Nevirapine—CYP2B6—Dexamethasone—hematologic cancer	0.00642	0.00888	CbGbCtD
Nevirapine—CYP3A4—Daunorubicin—hematologic cancer	0.00626	0.00866	CbGbCtD
Nevirapine—CYP3A5—Etoposide—hematologic cancer	0.00615	0.00851	CbGbCtD
Nevirapine—CYP3A4—Cytarabine—hematologic cancer	0.00552	0.00763	CbGbCtD
Nevirapine—CYP3A4—Teniposide—hematologic cancer	0.00544	0.00752	CbGbCtD
Nevirapine—CYP2B6—Doxorubicin—hematologic cancer	0.00533	0.00736	CbGbCtD
Nevirapine—CYP3A5—Dexamethasone—hematologic cancer	0.00506	0.00699	CbGbCtD
Nevirapine—CYP3A4—Ifosfamide—hematologic cancer	0.00502	0.00694	CbGbCtD
Nevirapine—CYP3A4—Imatinib—hematologic cancer	0.0048	0.00663	CbGbCtD
Nevirapine—CYP1A2—Etoposide—hematologic cancer	0.00458	0.00633	CbGbCtD
Nevirapine—CYP3A4—Ruxolitinib—hematologic cancer	0.00452	0.00624	CbGbCtD
Nevirapine—CYP3A4—Nilotinib—hematologic cancer	0.00436	0.00602	CbGbCtD
Nevirapine—CYP3A4—Vinorelbine—hematologic cancer	0.00432	0.00597	CbGbCtD
Nevirapine—CYP2C9—Cisplatin—hematologic cancer	0.0042	0.00581	CbGbCtD
Nevirapine—CYP2D6—Vinblastine—hematologic cancer	0.00419	0.00579	CbGbCtD
Nevirapine—CYP3A4—Triamcinolone—hematologic cancer	0.00395	0.00546	CbGbCtD
Nevirapine—CYP3A4—Dasatinib—hematologic cancer	0.00385	0.00532	CbGbCtD
Nevirapine—CYP3A4—Mitoxantrone—hematologic cancer	0.00381	0.00526	CbGbCtD
Nevirapine—CYP2C9—Dexamethasone—hematologic cancer	0.00339	0.00469	CbGbCtD
Nevirapine—CYP3A4—Betamethasone—hematologic cancer	0.00339	0.00469	CbGbCtD
Nevirapine—CYP3A4—Prednisolone—hematologic cancer	0.00335	0.00463	CbGbCtD
Nevirapine—CYP3A4—Prednisone—hematologic cancer	0.00316	0.00437	CbGbCtD
Nevirapine—CYP2D6—Dexamethasone—hematologic cancer	0.0031	0.00429	CbGbCtD
Nevirapine—CYP3A4—Irinotecan—hematologic cancer	0.003	0.00414	CbGbCtD
Nevirapine—CYP3A4—Vinblastine—hematologic cancer	0.00266	0.00368	CbGbCtD
Nevirapine—CYP3A4—Vincristine—hematologic cancer	0.00262	0.00362	CbGbCtD
Nevirapine—CYP2D6—Doxorubicin—hematologic cancer	0.00257	0.00356	CbGbCtD
Nevirapine—CYP3A4—Etoposide—hematologic cancer	0.0024	0.00332	CbGbCtD
Nevirapine—CYP3A4—Dexamethasone—hematologic cancer	0.00197	0.00273	CbGbCtD
Nevirapine—CYP3A4—Doxorubicin—hematologic cancer	0.00164	0.00226	CbGbCtD
Nevirapine—Renal failure—Doxorubicin—hematologic cancer	4.17e-05	0.000165	CcSEcCtD
Nevirapine—Rash—Ifosfamide—hematologic cancer	4.16e-05	0.000164	CcSEcCtD
Nevirapine—Dermatitis—Ifosfamide—hematologic cancer	4.16e-05	0.000164	CcSEcCtD
Nevirapine—Erythema multiforme—Methotrexate—hematologic cancer	4.16e-05	0.000164	CcSEcCtD
Nevirapine—Neuropathy peripheral—Doxorubicin—hematologic cancer	4.16e-05	0.000164	CcSEcCtD
Nevirapine—Urticaria—Etoposide—hematologic cancer	4.14e-05	0.000164	CcSEcCtD
Nevirapine—Jaundice—Doxorubicin—hematologic cancer	4.13e-05	0.000163	CcSEcCtD
Nevirapine—Malaise—Prednisone—hematologic cancer	4.13e-05	0.000163	CcSEcCtD
Nevirapine—Body temperature increased—Etoposide—hematologic cancer	4.12e-05	0.000163	CcSEcCtD
Nevirapine—Abdominal pain—Etoposide—hematologic cancer	4.12e-05	0.000163	CcSEcCtD
Nevirapine—Conjunctivitis—Doxorubicin—hematologic cancer	4.12e-05	0.000163	CcSEcCtD
Nevirapine—Hepatitis—Epirubicin—hematologic cancer	4.11e-05	0.000162	CcSEcCtD
Nevirapine—Vomiting—Vincristine—hematologic cancer	4.09e-05	0.000162	CcSEcCtD
Nevirapine—Anorexia—Dexamethasone—hematologic cancer	4.09e-05	0.000162	CcSEcCtD
Nevirapine—Anorexia—Betamethasone—hematologic cancer	4.09e-05	0.000162	CcSEcCtD
Nevirapine—Urticaria—Prednisolone—hematologic cancer	4.09e-05	0.000161	CcSEcCtD
Nevirapine—Asthenia—Cisplatin—hematologic cancer	4.08e-05	0.000161	CcSEcCtD
Nevirapine—Fatigue—Triamcinolone—hematologic cancer	4.08e-05	0.000161	CcSEcCtD
Nevirapine—Rash—Vincristine—hematologic cancer	4.06e-05	0.00016	CcSEcCtD
Nevirapine—Dermatitis—Vincristine—hematologic cancer	4.05e-05	0.00016	CcSEcCtD
Nevirapine—Pain—Triamcinolone—hematologic cancer	4.04e-05	0.00016	CcSEcCtD
Nevirapine—Connective tissue disorder—Epirubicin—hematologic cancer	4.04e-05	0.00016	CcSEcCtD
Nevirapine—Headache—Vincristine—hematologic cancer	4.03e-05	0.000159	CcSEcCtD
Nevirapine—Hepatobiliary disease—Doxorubicin—hematologic cancer	4.01e-05	0.000158	CcSEcCtD
Nevirapine—Nausea—Carmustine—hematologic cancer	4.01e-05	0.000158	CcSEcCtD
Nevirapine—Vomiting—Irinotecan—hematologic cancer	3.99e-05	0.000157	CcSEcCtD
Nevirapine—Vomiting—Mitoxantrone—hematologic cancer	3.99e-05	0.000157	CcSEcCtD
Nevirapine—Immune system disorder—Methotrexate—hematologic cancer	3.97e-05	0.000157	CcSEcCtD
Nevirapine—Nausea—Alitretinoin—hematologic cancer	3.97e-05	0.000157	CcSEcCtD
Nevirapine—Agranulocytosis—Doxorubicin—hematologic cancer	3.96e-05	0.000156	CcSEcCtD
Nevirapine—Rash—Mitoxantrone—hematologic cancer	3.95e-05	0.000156	CcSEcCtD
Nevirapine—Rash—Irinotecan—hematologic cancer	3.95e-05	0.000156	CcSEcCtD
Nevirapine—Dermatitis—Mitoxantrone—hematologic cancer	3.95e-05	0.000156	CcSEcCtD
Nevirapine—Dermatitis—Irinotecan—hematologic cancer	3.95e-05	0.000156	CcSEcCtD
Nevirapine—Headache—Irinotecan—hematologic cancer	3.93e-05	0.000155	CcSEcCtD
Nevirapine—Headache—Mitoxantrone—hematologic cancer	3.93e-05	0.000155	CcSEcCtD
Nevirapine—Nausea—Ifosfamide—hematologic cancer	3.92e-05	0.000155	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Betamethasone—hematologic cancer	3.91e-05	0.000154	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	3.91e-05	0.000154	CcSEcCtD
Nevirapine—Myalgia—Prednisone—hematologic cancer	3.9e-05	0.000154	CcSEcCtD
Nevirapine—Arthralgia—Prednisone—hematologic cancer	3.9e-05	0.000154	CcSEcCtD
Nevirapine—Feeling abnormal—Triamcinolone—hematologic cancer	3.9e-05	0.000154	CcSEcCtD
Nevirapine—Diarrhoea—Cisplatin—hematologic cancer	3.89e-05	0.000154	CcSEcCtD
Nevirapine—Erythema multiforme—Epirubicin—hematologic cancer	3.89e-05	0.000154	CcSEcCtD
Nevirapine—Vomiting—Gemcitabine—hematologic cancer	3.88e-05	0.000153	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	3.87e-05	0.000153	CcSEcCtD
Nevirapine—Paraesthesia—Betamethasone—hematologic cancer	3.85e-05	0.000152	CcSEcCtD
Nevirapine—Paraesthesia—Dexamethasone—hematologic cancer	3.85e-05	0.000152	CcSEcCtD
Nevirapine—Discomfort—Prednisone—hematologic cancer	3.85e-05	0.000152	CcSEcCtD
Nevirapine—Rash—Gemcitabine—hematologic cancer	3.85e-05	0.000152	CcSEcCtD
Nevirapine—Dermatitis—Gemcitabine—hematologic cancer	3.85e-05	0.000152	CcSEcCtD
Nevirapine—Hypersensitivity—Etoposide—hematologic cancer	3.84e-05	0.000152	CcSEcCtD
Nevirapine—Erythema—Methotrexate—hematologic cancer	3.83e-05	0.000151	CcSEcCtD
Nevirapine—Headache—Gemcitabine—hematologic cancer	3.83e-05	0.000151	CcSEcCtD
Nevirapine—Nausea—Vincristine—hematologic cancer	3.82e-05	0.000151	CcSEcCtD
Nevirapine—Hepatitis—Doxorubicin—hematologic cancer	3.81e-05	0.00015	CcSEcCtD
Nevirapine—Hypersensitivity—Prednisolone—hematologic cancer	3.79e-05	0.00015	CcSEcCtD
Nevirapine—Urticaria—Triamcinolone—hematologic cancer	3.76e-05	0.000148	CcSEcCtD
Nevirapine—Asthenia—Etoposide—hematologic cancer	3.74e-05	0.000148	CcSEcCtD
Nevirapine—Connective tissue disorder—Doxorubicin—hematologic cancer	3.74e-05	0.000148	CcSEcCtD
Nevirapine—Body temperature increased—Triamcinolone—hematologic cancer	3.74e-05	0.000148	CcSEcCtD
Nevirapine—Anaphylactic shock—Prednisone—hematologic cancer	3.74e-05	0.000148	CcSEcCtD
Nevirapine—Oedema—Prednisone—hematologic cancer	3.74e-05	0.000148	CcSEcCtD
Nevirapine—Decreased appetite—Dexamethasone—hematologic cancer	3.73e-05	0.000147	CcSEcCtD
Nevirapine—Decreased appetite—Betamethasone—hematologic cancer	3.73e-05	0.000147	CcSEcCtD
Nevirapine—Nausea—Irinotecan—hematologic cancer	3.72e-05	0.000147	CcSEcCtD
Nevirapine—Nausea—Mitoxantrone—hematologic cancer	3.72e-05	0.000147	CcSEcCtD
Nevirapine—Immune system disorder—Epirubicin—hematologic cancer	3.72e-05	0.000147	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Betamethasone—hematologic cancer	3.7e-05	0.000146	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Dexamethasone—hematologic cancer	3.7e-05	0.000146	CcSEcCtD
Nevirapine—Fatigue—Dexamethasone—hematologic cancer	3.7e-05	0.000146	CcSEcCtD
Nevirapine—Fatigue—Betamethasone—hematologic cancer	3.7e-05	0.000146	CcSEcCtD
Nevirapine—Pruritus—Etoposide—hematologic cancer	3.69e-05	0.000146	CcSEcCtD
Nevirapine—Pain—Betamethasone—hematologic cancer	3.67e-05	0.000145	CcSEcCtD
Nevirapine—Pain—Dexamethasone—hematologic cancer	3.67e-05	0.000145	CcSEcCtD
Nevirapine—Nervous system disorder—Prednisone—hematologic cancer	3.66e-05	0.000145	CcSEcCtD
Nevirapine—Skin disorder—Prednisone—hematologic cancer	3.63e-05	0.000143	CcSEcCtD
Nevirapine—Nausea—Gemcitabine—hematologic cancer	3.63e-05	0.000143	CcSEcCtD
Nevirapine—Vomiting—Cisplatin—hematologic cancer	3.62e-05	0.000143	CcSEcCtD
Nevirapine—Erythema multiforme—Doxorubicin—hematologic cancer	3.6e-05	0.000142	CcSEcCtD
Nevirapine—Rash—Cisplatin—hematologic cancer	3.59e-05	0.000142	CcSEcCtD
Nevirapine—Dermatitis—Cisplatin—hematologic cancer	3.59e-05	0.000142	CcSEcCtD
Nevirapine—Erythema—Epirubicin—hematologic cancer	3.58e-05	0.000141	CcSEcCtD
Nevirapine—Diarrhoea—Etoposide—hematologic cancer	3.57e-05	0.000141	CcSEcCtD
Nevirapine—Anorexia—Prednisone—hematologic cancer	3.56e-05	0.000141	CcSEcCtD
Nevirapine—Ill-defined disorder—Methotrexate—hematologic cancer	3.55e-05	0.00014	CcSEcCtD
Nevirapine—Anaemia—Methotrexate—hematologic cancer	3.54e-05	0.00014	CcSEcCtD
Nevirapine—Feeling abnormal—Dexamethasone—hematologic cancer	3.54e-05	0.00014	CcSEcCtD
Nevirapine—Feeling abnormal—Betamethasone—hematologic cancer	3.54e-05	0.00014	CcSEcCtD
Nevirapine—Gastrointestinal pain—Dexamethasone—hematologic cancer	3.51e-05	0.000139	CcSEcCtD
Nevirapine—Gastrointestinal pain—Betamethasone—hematologic cancer	3.51e-05	0.000139	CcSEcCtD
Nevirapine—Hypersensitivity—Triamcinolone—hematologic cancer	3.48e-05	0.000138	CcSEcCtD
Nevirapine—Malaise—Methotrexate—hematologic cancer	3.45e-05	0.000136	CcSEcCtD
Nevirapine—Immune system disorder—Doxorubicin—hematologic cancer	3.44e-05	0.000136	CcSEcCtD
Nevirapine—Urticaria—Dexamethasone—hematologic cancer	3.41e-05	0.000135	CcSEcCtD
Nevirapine—Urticaria—Betamethasone—hematologic cancer	3.41e-05	0.000135	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Prednisone—hematologic cancer	3.4e-05	0.000134	CcSEcCtD
Nevirapine—Asthenia—Triamcinolone—hematologic cancer	3.39e-05	0.000134	CcSEcCtD
Nevirapine—Abdominal pain—Dexamethasone—hematologic cancer	3.39e-05	0.000134	CcSEcCtD
Nevirapine—Body temperature increased—Dexamethasone—hematologic cancer	3.39e-05	0.000134	CcSEcCtD
Nevirapine—Body temperature increased—Betamethasone—hematologic cancer	3.39e-05	0.000134	CcSEcCtD
Nevirapine—Abdominal pain—Betamethasone—hematologic cancer	3.39e-05	0.000134	CcSEcCtD
Nevirapine—Nausea—Cisplatin—hematologic cancer	3.38e-05	0.000133	CcSEcCtD
Nevirapine—Paraesthesia—Prednisone—hematologic cancer	3.36e-05	0.000133	CcSEcCtD
Nevirapine—Pruritus—Triamcinolone—hematologic cancer	3.35e-05	0.000132	CcSEcCtD
Nevirapine—Ill-defined disorder—Epirubicin—hematologic cancer	3.32e-05	0.000131	CcSEcCtD
Nevirapine—Vomiting—Etoposide—hematologic cancer	3.32e-05	0.000131	CcSEcCtD
Nevirapine—Erythema—Doxorubicin—hematologic cancer	3.31e-05	0.000131	CcSEcCtD
Nevirapine—Anaemia—Epirubicin—hematologic cancer	3.31e-05	0.000131	CcSEcCtD
Nevirapine—Rash—Etoposide—hematologic cancer	3.29e-05	0.00013	CcSEcCtD
Nevirapine—Dermatitis—Etoposide—hematologic cancer	3.28e-05	0.00013	CcSEcCtD
Nevirapine—Headache—Etoposide—hematologic cancer	3.27e-05	0.000129	CcSEcCtD
Nevirapine—Myalgia—Methotrexate—hematologic cancer	3.26e-05	0.000129	CcSEcCtD
Nevirapine—Arthralgia—Methotrexate—hematologic cancer	3.26e-05	0.000129	CcSEcCtD
Nevirapine—Decreased appetite—Prednisone—hematologic cancer	3.25e-05	0.000128	CcSEcCtD
Nevirapine—Rash—Prednisolone—hematologic cancer	3.24e-05	0.000128	CcSEcCtD
Nevirapine—Dermatitis—Prednisolone—hematologic cancer	3.24e-05	0.000128	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	3.24e-05	0.000128	CcSEcCtD
Nevirapine—Malaise—Epirubicin—hematologic cancer	3.23e-05	0.000128	CcSEcCtD
Nevirapine—Fatigue—Prednisone—hematologic cancer	3.22e-05	0.000127	CcSEcCtD
Nevirapine—Headache—Prednisolone—hematologic cancer	3.22e-05	0.000127	CcSEcCtD
Nevirapine—Discomfort—Methotrexate—hematologic cancer	3.22e-05	0.000127	CcSEcCtD
Nevirapine—Anaphylactic shock—Methotrexate—hematologic cancer	3.12e-05	0.000123	CcSEcCtD
Nevirapine—Nausea—Etoposide—hematologic cancer	3.1e-05	0.000122	CcSEcCtD
Nevirapine—Feeling abnormal—Prednisone—hematologic cancer	3.08e-05	0.000122	CcSEcCtD
Nevirapine—Asthenia—Dexamethasone—hematologic cancer	3.08e-05	0.000122	CcSEcCtD
Nevirapine—Asthenia—Betamethasone—hematologic cancer	3.08e-05	0.000122	CcSEcCtD
Nevirapine—Ill-defined disorder—Doxorubicin—hematologic cancer	3.07e-05	0.000121	CcSEcCtD
Nevirapine—Nervous system disorder—Methotrexate—hematologic cancer	3.06e-05	0.000121	CcSEcCtD
Nevirapine—Anaemia—Doxorubicin—hematologic cancer	3.06e-05	0.000121	CcSEcCtD
Nevirapine—Thrombocytopenia—Methotrexate—hematologic cancer	3.06e-05	0.000121	CcSEcCtD
Nevirapine—Gastrointestinal pain—Prednisone—hematologic cancer	3.06e-05	0.000121	CcSEcCtD
Nevirapine—Nausea—Prednisolone—hematologic cancer	3.05e-05	0.000121	CcSEcCtD
Nevirapine—Myalgia—Epirubicin—hematologic cancer	3.05e-05	0.00012	CcSEcCtD
Nevirapine—Arthralgia—Epirubicin—hematologic cancer	3.05e-05	0.00012	CcSEcCtD
Nevirapine—Pruritus—Betamethasone—hematologic cancer	3.04e-05	0.00012	CcSEcCtD
Nevirapine—Pruritus—Dexamethasone—hematologic cancer	3.04e-05	0.00012	CcSEcCtD
Nevirapine—Skin disorder—Methotrexate—hematologic cancer	3.03e-05	0.00012	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	3.03e-05	0.00012	CcSEcCtD
Nevirapine—Discomfort—Epirubicin—hematologic cancer	3.01e-05	0.000119	CcSEcCtD
Nevirapine—Vomiting—Triamcinolone—hematologic cancer	3.01e-05	0.000119	CcSEcCtD
Nevirapine—Malaise—Doxorubicin—hematologic cancer	2.99e-05	0.000118	CcSEcCtD
Nevirapine—Rash—Triamcinolone—hematologic cancer	2.98e-05	0.000118	CcSEcCtD
Nevirapine—Dermatitis—Triamcinolone—hematologic cancer	2.98e-05	0.000118	CcSEcCtD
Nevirapine—Anorexia—Methotrexate—hematologic cancer	2.98e-05	0.000118	CcSEcCtD
Nevirapine—Urticaria—Prednisone—hematologic cancer	2.97e-05	0.000117	CcSEcCtD
Nevirapine—Headache—Triamcinolone—hematologic cancer	2.96e-05	0.000117	CcSEcCtD
Nevirapine—Abdominal pain—Prednisone—hematologic cancer	2.95e-05	0.000117	CcSEcCtD
Nevirapine—Body temperature increased—Prednisone—hematologic cancer	2.95e-05	0.000117	CcSEcCtD
Nevirapine—Diarrhoea—Betamethasone—hematologic cancer	2.94e-05	0.000116	CcSEcCtD
Nevirapine—Diarrhoea—Dexamethasone—hematologic cancer	2.94e-05	0.000116	CcSEcCtD
Nevirapine—Oedema—Epirubicin—hematologic cancer	2.92e-05	0.000115	CcSEcCtD
Nevirapine—Anaphylactic shock—Epirubicin—hematologic cancer	2.92e-05	0.000115	CcSEcCtD
Nevirapine—Nervous system disorder—Epirubicin—hematologic cancer	2.87e-05	0.000113	CcSEcCtD
Nevirapine—Thrombocytopenia—Epirubicin—hematologic cancer	2.86e-05	0.000113	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.85e-05	0.000112	CcSEcCtD
Nevirapine—Skin disorder—Epirubicin—hematologic cancer	2.84e-05	0.000112	CcSEcCtD
Nevirapine—Arthralgia—Doxorubicin—hematologic cancer	2.82e-05	0.000111	CcSEcCtD
Nevirapine—Myalgia—Doxorubicin—hematologic cancer	2.82e-05	0.000111	CcSEcCtD
Nevirapine—Nausea—Triamcinolone—hematologic cancer	2.81e-05	0.000111	CcSEcCtD
Nevirapine—Paraesthesia—Methotrexate—hematologic cancer	2.8e-05	0.000111	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.8e-05	0.000111	CcSEcCtD
Nevirapine—Discomfort—Doxorubicin—hematologic cancer	2.79e-05	0.00011	CcSEcCtD
Nevirapine—Anorexia—Epirubicin—hematologic cancer	2.79e-05	0.00011	CcSEcCtD
Nevirapine—Somnolence—Methotrexate—hematologic cancer	2.78e-05	0.00011	CcSEcCtD
Nevirapine—Hypersensitivity—Prednisone—hematologic cancer	2.75e-05	0.000109	CcSEcCtD
Nevirapine—Vomiting—Betamethasone—hematologic cancer	2.73e-05	0.000108	CcSEcCtD
Nevirapine—Vomiting—Dexamethasone—hematologic cancer	2.73e-05	0.000108	CcSEcCtD
Nevirapine—Decreased appetite—Methotrexate—hematologic cancer	2.71e-05	0.000107	CcSEcCtD
Nevirapine—Rash—Betamethasone—hematologic cancer	2.71e-05	0.000107	CcSEcCtD
Nevirapine—Rash—Dexamethasone—hematologic cancer	2.71e-05	0.000107	CcSEcCtD
Nevirapine—Anaphylactic shock—Doxorubicin—hematologic cancer	2.7e-05	0.000107	CcSEcCtD
Nevirapine—Oedema—Doxorubicin—hematologic cancer	2.7e-05	0.000107	CcSEcCtD
Nevirapine—Dermatitis—Betamethasone—hematologic cancer	2.7e-05	0.000107	CcSEcCtD
Nevirapine—Dermatitis—Dexamethasone—hematologic cancer	2.7e-05	0.000107	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.7e-05	0.000106	CcSEcCtD
Nevirapine—Fatigue—Methotrexate—hematologic cancer	2.69e-05	0.000106	CcSEcCtD
Nevirapine—Headache—Betamethasone—hematologic cancer	2.69e-05	0.000106	CcSEcCtD
Nevirapine—Headache—Dexamethasone—hematologic cancer	2.69e-05	0.000106	CcSEcCtD
Nevirapine—Asthenia—Prednisone—hematologic cancer	2.68e-05	0.000106	CcSEcCtD
Nevirapine—Pain—Methotrexate—hematologic cancer	2.67e-05	0.000105	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.66e-05	0.000105	CcSEcCtD
Nevirapine—Nervous system disorder—Doxorubicin—hematologic cancer	2.65e-05	0.000105	CcSEcCtD
Nevirapine—Thrombocytopenia—Doxorubicin—hematologic cancer	2.65e-05	0.000105	CcSEcCtD
Nevirapine—Pruritus—Prednisone—hematologic cancer	2.64e-05	0.000104	CcSEcCtD
Nevirapine—Skin disorder—Doxorubicin—hematologic cancer	2.63e-05	0.000104	CcSEcCtD
Nevirapine—Paraesthesia—Epirubicin—hematologic cancer	2.62e-05	0.000104	CcSEcCtD
Nevirapine—Somnolence—Epirubicin—hematologic cancer	2.6e-05	0.000103	CcSEcCtD
Nevirapine—Anorexia—Doxorubicin—hematologic cancer	2.58e-05	0.000102	CcSEcCtD
Nevirapine—Feeling abnormal—Methotrexate—hematologic cancer	2.57e-05	0.000102	CcSEcCtD
Nevirapine—Diarrhoea—Prednisone—hematologic cancer	2.56e-05	0.000101	CcSEcCtD
Nevirapine—Gastrointestinal pain—Methotrexate—hematologic cancer	2.55e-05	0.000101	CcSEcCtD
Nevirapine—Nausea—Betamethasone—hematologic cancer	2.55e-05	0.000101	CcSEcCtD
Nevirapine—Nausea—Dexamethasone—hematologic cancer	2.55e-05	0.000101	CcSEcCtD
Nevirapine—Decreased appetite—Epirubicin—hematologic cancer	2.54e-05	0.0001	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.52e-05	9.96e-05	CcSEcCtD
Nevirapine—Fatigue—Epirubicin—hematologic cancer	2.52e-05	9.95e-05	CcSEcCtD
Nevirapine—Pain—Epirubicin—hematologic cancer	2.5e-05	9.87e-05	CcSEcCtD
Nevirapine—Urticaria—Methotrexate—hematologic cancer	2.48e-05	9.8e-05	CcSEcCtD
Nevirapine—Abdominal pain—Methotrexate—hematologic cancer	2.47e-05	9.75e-05	CcSEcCtD
Nevirapine—Body temperature increased—Methotrexate—hematologic cancer	2.47e-05	9.75e-05	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.46e-05	9.73e-05	CcSEcCtD
Nevirapine—Paraesthesia—Doxorubicin—hematologic cancer	2.43e-05	9.59e-05	CcSEcCtD
Nevirapine—Feeling abnormal—Epirubicin—hematologic cancer	2.41e-05	9.51e-05	CcSEcCtD
Nevirapine—Somnolence—Doxorubicin—hematologic cancer	2.4e-05	9.49e-05	CcSEcCtD
Nevirapine—Gastrointestinal pain—Epirubicin—hematologic cancer	2.39e-05	9.44e-05	CcSEcCtD
Nevirapine—Vomiting—Prednisone—hematologic cancer	2.38e-05	9.38e-05	CcSEcCtD
Nevirapine—Rash—Prednisone—hematologic cancer	2.36e-05	9.3e-05	CcSEcCtD
Nevirapine—Dermatitis—Prednisone—hematologic cancer	2.35e-05	9.3e-05	CcSEcCtD
Nevirapine—Decreased appetite—Doxorubicin—hematologic cancer	2.35e-05	9.28e-05	CcSEcCtD
Nevirapine—Headache—Prednisone—hematologic cancer	2.34e-05	9.24e-05	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.33e-05	9.22e-05	CcSEcCtD
Nevirapine—Fatigue—Doxorubicin—hematologic cancer	2.33e-05	9.21e-05	CcSEcCtD
Nevirapine—Urticaria—Epirubicin—hematologic cancer	2.32e-05	9.17e-05	CcSEcCtD
Nevirapine—Pain—Doxorubicin—hematologic cancer	2.31e-05	9.13e-05	CcSEcCtD
Nevirapine—Abdominal pain—Epirubicin—hematologic cancer	2.31e-05	9.12e-05	CcSEcCtD
Nevirapine—Body temperature increased—Epirubicin—hematologic cancer	2.31e-05	9.12e-05	CcSEcCtD
Nevirapine—Hypersensitivity—Methotrexate—hematologic cancer	2.3e-05	9.09e-05	CcSEcCtD
Nevirapine—Asthenia—Methotrexate—hematologic cancer	2.24e-05	8.85e-05	CcSEcCtD
Nevirapine—Feeling abnormal—Doxorubicin—hematologic cancer	2.23e-05	8.8e-05	CcSEcCtD
Nevirapine—Nausea—Prednisone—hematologic cancer	2.22e-05	8.77e-05	CcSEcCtD
Nevirapine—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.21e-05	8.73e-05	CcSEcCtD
Nevirapine—Pruritus—Methotrexate—hematologic cancer	2.21e-05	8.73e-05	CcSEcCtD
Nevirapine—Hypersensitivity—Epirubicin—hematologic cancer	2.15e-05	8.5e-05	CcSEcCtD
Nevirapine—Urticaria—Doxorubicin—hematologic cancer	2.15e-05	8.48e-05	CcSEcCtD
Nevirapine—Body temperature increased—Doxorubicin—hematologic cancer	2.14e-05	8.44e-05	CcSEcCtD
Nevirapine—Abdominal pain—Doxorubicin—hematologic cancer	2.14e-05	8.44e-05	CcSEcCtD
Nevirapine—Diarrhoea—Methotrexate—hematologic cancer	2.14e-05	8.44e-05	CcSEcCtD
Nevirapine—Asthenia—Epirubicin—hematologic cancer	2.1e-05	8.28e-05	CcSEcCtD
Nevirapine—Pruritus—Epirubicin—hematologic cancer	2.07e-05	8.17e-05	CcSEcCtD
Nevirapine—Diarrhoea—Epirubicin—hematologic cancer	2e-05	7.9e-05	CcSEcCtD
Nevirapine—Hypersensitivity—Doxorubicin—hematologic cancer	1.99e-05	7.87e-05	CcSEcCtD
Nevirapine—Vomiting—Methotrexate—hematologic cancer	1.99e-05	7.84e-05	CcSEcCtD
Nevirapine—Rash—Methotrexate—hematologic cancer	1.97e-05	7.78e-05	CcSEcCtD
Nevirapine—Dermatitis—Methotrexate—hematologic cancer	1.97e-05	7.77e-05	CcSEcCtD
Nevirapine—Headache—Methotrexate—hematologic cancer	1.96e-05	7.73e-05	CcSEcCtD
Nevirapine—Asthenia—Doxorubicin—hematologic cancer	1.94e-05	7.66e-05	CcSEcCtD
Nevirapine—Pruritus—Doxorubicin—hematologic cancer	1.91e-05	7.56e-05	CcSEcCtD
Nevirapine—Vomiting—Epirubicin—hematologic cancer	1.86e-05	7.34e-05	CcSEcCtD
Nevirapine—Nausea—Methotrexate—hematologic cancer	1.86e-05	7.33e-05	CcSEcCtD
Nevirapine—Diarrhoea—Doxorubicin—hematologic cancer	1.85e-05	7.31e-05	CcSEcCtD
Nevirapine—Rash—Epirubicin—hematologic cancer	1.84e-05	7.28e-05	CcSEcCtD
Nevirapine—Dermatitis—Epirubicin—hematologic cancer	1.84e-05	7.27e-05	CcSEcCtD
Nevirapine—Headache—Epirubicin—hematologic cancer	1.83e-05	7.23e-05	CcSEcCtD
Nevirapine—Nausea—Epirubicin—hematologic cancer	1.74e-05	6.86e-05	CcSEcCtD
Nevirapine—Vomiting—Doxorubicin—hematologic cancer	1.72e-05	6.79e-05	CcSEcCtD
Nevirapine—Rash—Doxorubicin—hematologic cancer	1.71e-05	6.73e-05	CcSEcCtD
Nevirapine—Dermatitis—Doxorubicin—hematologic cancer	1.7e-05	6.73e-05	CcSEcCtD
Nevirapine—Headache—Doxorubicin—hematologic cancer	1.69e-05	6.69e-05	CcSEcCtD
Nevirapine—Nausea—Doxorubicin—hematologic cancer	1.61e-05	6.34e-05	CcSEcCtD
Nevirapine—CYP2B6—Metabolism—SDC1—hematologic cancer	6.23e-06	0.000267	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—CYCS—hematologic cancer	6.22e-06	0.000267	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—HSP90AA1—hematologic cancer	6.18e-06	0.000265	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CA9—hematologic cancer	6.15e-06	0.000264	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ACP5—hematologic cancer	6.15e-06	0.000264	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—FHL2—hematologic cancer	6.13e-06	0.000263	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CA9—hematologic cancer	6.1e-06	0.000261	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ACP5—hematologic cancer	6.1e-06	0.000261	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—SDC1—hematologic cancer	6.09e-06	0.000261	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—NCOR2—hematologic cancer	6.07e-06	0.00026	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—NCOR2—hematologic cancer	6.02e-06	0.000258	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—AGRN—hematologic cancer	6.01e-06	0.000258	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PC—hematologic cancer	6.01e-06	0.000258	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GBA—hematologic cancer	5.8e-06	0.000249	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—SLC35B2—hematologic cancer	5.8e-06	0.000249	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—IDH1—hematologic cancer	5.78e-06	0.000248	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—IDH1—hematologic cancer	5.73e-06	0.000246	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ABCC3—hematologic cancer	5.72e-06	0.000245	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—TXN—hematologic cancer	5.72e-06	0.000245	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GSTO1—hematologic cancer	5.72e-06	0.000245	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—IDH2—hematologic cancer	5.7e-06	0.000244	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—HMMR—hematologic cancer	5.7e-06	0.000244	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GSTO1—hematologic cancer	5.67e-06	0.000243	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ABCC3—hematologic cancer	5.67e-06	0.000243	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—TXN—hematologic cancer	5.67e-06	0.000243	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—SPHK1—hematologic cancer	5.59e-06	0.00024	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—SPHK1—hematologic cancer	5.55e-06	0.000238	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—GSTP1—hematologic cancer	5.48e-06	0.000235	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—UGT1A1—hematologic cancer	5.37e-06	0.000231	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	5.37e-06	0.00023	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ARNTL—hematologic cancer	5.36e-06	0.00023	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—UGT1A1—hematologic cancer	5.33e-06	0.000229	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—MTAP—hematologic cancer	5.31e-06	0.000228	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—NQO1—hematologic cancer	5.3e-06	0.000227	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CD44—hematologic cancer	5.3e-06	0.000227	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—SLC22A1—hematologic cancer	5.23e-06	0.000224	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CRABP1—hematologic cancer	5.23e-06	0.000224	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CA9—hematologic cancer	5.21e-06	0.000223	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ACP5—hematologic cancer	5.21e-06	0.000223	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—ABCB1—hematologic cancer	5.19e-06	0.000222	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—SLC22A1—hematologic cancer	5.18e-06	0.000222	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CRABP1—hematologic cancer	5.18e-06	0.000222	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CD44—hematologic cancer	5.18e-06	0.000222	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—NQO1—hematologic cancer	5.18e-06	0.000222	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—NCOR2—hematologic cancer	5.14e-06	0.000221	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ALOX5—hematologic cancer	5.1e-06	0.000219	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ALOX5—hematologic cancer	5.05e-06	0.000217	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—NCOR1—hematologic cancer	5.03e-06	0.000216	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—GSTM1—hematologic cancer	5.03e-06	0.000216	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CYCS—hematologic cancer	5.02e-06	0.000215	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—HSP90AA1—hematologic cancer	4.98e-06	0.000214	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—NUP98—hematologic cancer	4.93e-06	0.000212	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CYCS—hematologic cancer	4.9e-06	0.00021	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—IDH1—hematologic cancer	4.9e-06	0.00021	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—NUP98—hematologic cancer	4.89e-06	0.00021	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—HSP90AA1—hematologic cancer	4.87e-06	0.000209	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ABCC3—hematologic cancer	4.84e-06	0.000208	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—TXN—hematologic cancer	4.84e-06	0.000208	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GSTO1—hematologic cancer	4.84e-06	0.000208	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ADCY7—hematologic cancer	4.79e-06	0.000205	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—NCOA3—hematologic cancer	4.79e-06	0.000205	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—NUP214—hematologic cancer	4.76e-06	0.000204	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ADCY7—hematologic cancer	4.75e-06	0.000204	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—NCOA3—hematologic cancer	4.75e-06	0.000204	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—SPHK1—hematologic cancer	4.74e-06	0.000203	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—FHL2—hematologic cancer	4.73e-06	0.000203	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—NUP214—hematologic cancer	4.72e-06	0.000202	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.67e-06	0.0002	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ABCG2—hematologic cancer	4.66e-06	0.0002	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—MTR—hematologic cancer	4.66e-06	0.0002	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—AGRN—hematologic cancer	4.64e-06	0.000199	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—MTR—hematologic cancer	4.62e-06	0.000198	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ABCG2—hematologic cancer	4.62e-06	0.000198	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ENO2—hematologic cancer	4.57e-06	0.000196	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—UGT1A1—hematologic cancer	4.55e-06	0.000195	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ENO2—hematologic cancer	4.53e-06	0.000194	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—MTHFR—hematologic cancer	4.45e-06	0.000191	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GSTT1—hematologic cancer	4.43e-06	0.00019	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CRABP1—hematologic cancer	4.43e-06	0.00019	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—SLC22A1—hematologic cancer	4.43e-06	0.00019	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—GSTP1—hematologic cancer	4.42e-06	0.00019	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—HMMR—hematologic cancer	4.4e-06	0.000189	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—IDH2—hematologic cancer	4.4e-06	0.000189	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GSTT1—hematologic cancer	4.39e-06	0.000188	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—SDC1—hematologic cancer	4.33e-06	0.000186	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.33e-06	0.000186	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—GSTP1—hematologic cancer	4.32e-06	0.000185	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ALOX5—hematologic cancer	4.32e-06	0.000185	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—SDC1—hematologic cancer	4.3e-06	0.000184	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—ABCB1—hematologic cancer	4.18e-06	0.000179	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—NUP98—hematologic cancer	4.18e-06	0.000179	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ARNTL—hematologic cancer	4.13e-06	0.000177	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.1e-06	0.000176	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—ABCB1—hematologic cancer	4.09e-06	0.000175	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—NCOR1—hematologic cancer	4.06e-06	0.000174	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—GSTM1—hematologic cancer	4.06e-06	0.000174	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ADCY7—hematologic cancer	4.06e-06	0.000174	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—NCOA3—hematologic cancer	4.06e-06	0.000174	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.05e-06	0.000174	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—NUP214—hematologic cancer	4.03e-06	0.000173	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ACP5—hematologic cancer	4.02e-06	0.000172	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CA9—hematologic cancer	4.02e-06	0.000172	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	3.99e-06	0.000171	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—GSTM1—hematologic cancer	3.97e-06	0.00017	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—NCOR1—hematologic cancer	3.97e-06	0.00017	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—NCOR2—hematologic cancer	3.97e-06	0.00017	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ABCG2—hematologic cancer	3.95e-06	0.000169	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—MTR—hematologic cancer	3.95e-06	0.000169	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.87e-06	0.000166	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ENO2—hematologic cancer	3.87e-06	0.000166	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—IDH1—hematologic cancer	3.78e-06	0.000162	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GSTT1—hematologic cancer	3.76e-06	0.000161	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PIK3CG—hematologic cancer	3.74e-06	0.00016	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—TXN—hematologic cancer	3.74e-06	0.00016	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ABCC3—hematologic cancer	3.74e-06	0.00016	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GSTO1—hematologic cancer	3.74e-06	0.00016	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.7e-06	0.000159	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CD44—hematologic cancer	3.68e-06	0.000158	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—NQO1—hematologic cancer	3.68e-06	0.000158	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—SDC1—hematologic cancer	3.67e-06	0.000157	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—SPHK1—hematologic cancer	3.66e-06	0.000157	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—NQO1—hematologic cancer	3.65e-06	0.000157	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CD44—hematologic cancer	3.65e-06	0.000157	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—MTHFR—hematologic cancer	3.59e-06	0.000154	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.58e-06	0.000153	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	3.51e-06	0.000151	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—MTHFR—hematologic cancer	3.51e-06	0.000151	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.51e-06	0.00015	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CYCS—hematologic cancer	3.49e-06	0.00015	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—CREBBP—hematologic cancer	3.47e-06	0.000149	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	3.46e-06	0.000149	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.46e-06	0.000148	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CYCS—hematologic cancer	3.46e-06	0.000148	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	3.43e-06	0.000147	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.42e-06	0.000147	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.42e-06	0.000147	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ALOX5—hematologic cancer	3.33e-06	0.000143	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.31e-06	0.000142	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PIK3CD—hematologic cancer	3.29e-06	0.000141	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—ALB—hematologic cancer	3.24e-06	0.000139	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—NUP98—hematologic cancer	3.23e-06	0.000138	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.13e-06	0.000134	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.13e-06	0.000134	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CD44—hematologic cancer	3.12e-06	0.000134	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—NQO1—hematologic cancer	3.12e-06	0.000134	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—NUP214—hematologic cancer	3.11e-06	0.000133	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PIK3R1—hematologic cancer	3.1e-06	0.000133	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.09e-06	0.000133	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GSTP1—hematologic cancer	3.07e-06	0.000132	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.06e-06	0.000131	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—MTR—hematologic cancer	3.05e-06	0.000131	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.05e-06	0.000131	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GSTP1—hematologic cancer	3.05e-06	0.000131	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PIK3CG—hematologic cancer	3.02e-06	0.000129	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ENO2—hematologic cancer	2.99e-06	0.000128	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CYCS—hematologic cancer	2.95e-06	0.000127	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PIK3CG—hematologic cancer	2.95e-06	0.000126	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.95e-06	0.000126	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	2.93e-06	0.000126	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ABCB1—hematologic cancer	2.91e-06	0.000125	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.9e-06	0.000124	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ABCB1—hematologic cancer	2.88e-06	0.000124	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PIK3CB—hematologic cancer	2.86e-06	0.000123	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—SDC1—hematologic cancer	2.83e-06	0.000122	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GSTM1—hematologic cancer	2.82e-06	0.000121	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—NCOR1—hematologic cancer	2.82e-06	0.000121	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GSTM1—hematologic cancer	2.8e-06	0.00012	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—NCOR1—hematologic cancer	2.8e-06	0.00012	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CREBBP—hematologic cancer	2.8e-06	0.00012	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CREBBP—hematologic cancer	2.73e-06	0.000117	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PIK3CD—hematologic cancer	2.65e-06	0.000114	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.64e-06	0.000113	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—ALB—hematologic cancer	2.62e-06	0.000112	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GSTP1—hematologic cancer	2.6e-06	0.000112	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PIK3CD—hematologic cancer	2.59e-06	0.000111	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—ALB—hematologic cancer	2.56e-06	0.00011	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.52e-06	0.000108	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PIK3R1—hematologic cancer	2.5e-06	0.000107	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—MTHFR—hematologic cancer	2.5e-06	0.000107	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PTEN—hematologic cancer	2.48e-06	0.000106	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—MTHFR—hematologic cancer	2.47e-06	0.000106	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ABCB1—hematologic cancer	2.46e-06	0.000106	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PIK3R1—hematologic cancer	2.45e-06	0.000105	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CD44—hematologic cancer	2.41e-06	0.000103	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—NQO1—hematologic cancer	2.41e-06	0.000103	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GSTM1—hematologic cancer	2.39e-06	0.000103	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—NCOR1—hematologic cancer	2.39e-06	0.000103	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—EP300—hematologic cancer	2.36e-06	0.000101	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PIK3CB—hematologic cancer	2.31e-06	9.91e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CYCS—hematologic cancer	2.28e-06	9.78e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.26e-06	9.71e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PIK3CB—hematologic cancer	2.26e-06	9.69e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.18e-06	9.35e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—MTHFR—hematologic cancer	2.11e-06	9.07e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	2.1e-06	8.99e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PIK3CG—hematologic cancer	2.08e-06	8.92e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.01e-06	8.62e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PTEN—hematologic cancer	2e-06	8.57e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PTEN—hematologic cancer	1.95e-06	8.37e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CREBBP—hematologic cancer	1.94e-06	8.34e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CREBBP—hematologic cancer	1.93e-06	8.27e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—EP300—hematologic cancer	1.9e-06	8.17e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.9e-06	8.16e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.86e-06	7.99e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—EP300—hematologic cancer	1.86e-06	7.99e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.85e-06	7.92e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.85e-06	7.92e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.84e-06	7.91e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.83e-06	7.84e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ALB—hematologic cancer	1.82e-06	7.8e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ALB—hematologic cancer	1.8e-06	7.74e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.78e-06	7.62e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PIK3CA—hematologic cancer	1.75e-06	7.49e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.74e-06	7.47e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.73e-06	7.4e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.65e-06	7.06e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.63e-06	7e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.61e-06	6.89e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.59e-06	6.83e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.56e-06	6.7e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ALB—hematologic cancer	1.54e-06	6.61e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.47e-06	6.32e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—AKT1—hematologic cancer	1.43e-06	6.12e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PIK3CA—hematologic cancer	1.41e-06	6.04e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PTEN—hematologic cancer	1.39e-06	5.95e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PIK3CA—hematologic cancer	1.38e-06	5.91e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PTEN—hematologic cancer	1.38e-06	5.9e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.37e-06	5.88e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.36e-06	5.84e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—EP300—hematologic cancer	1.32e-06	5.68e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—EP300—hematologic cancer	1.31e-06	5.63e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.27e-06	5.45e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.21e-06	5.17e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ALB—hematologic cancer	1.19e-06	5.1e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PTEN—hematologic cancer	1.18e-06	5.04e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—AKT1—hematologic cancer	1.15e-06	4.94e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.14e-06	4.88e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—AKT1—hematologic cancer	1.13e-06	4.83e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—EP300—hematologic cancer	1.12e-06	4.81e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.05e-06	4.51e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	9.79e-07	4.2e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PIK3CA—hematologic cancer	9.71e-07	4.16e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PTEN—hematologic cancer	9.08e-07	3.89e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—EP300—hematologic cancer	8.66e-07	3.71e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PIK3CA—hematologic cancer	8.3e-07	3.56e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—AKT1—hematologic cancer	8e-07	3.43e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—AKT1—hematologic cancer	7.93e-07	3.4e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—AKT1—hematologic cancer	6.78e-07	2.91e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	6.4e-07	2.75e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—AKT1—hematologic cancer	5.23e-07	2.24e-05	CbGpPWpGaD
